Philips Launches Two Portable Biomedical Products In US
The Tempus Pro and Tempus ALS allow medical personnel to conduct defibrillation and video laryngoscopies in a portable setting, and upload patient data in real-time while in-transit. Photo courtesy of Philips.

Philips has announced the launch of two portable biomedical products, after obtaining FDA approval for them: the Tempus ALS and Tempus Pro. Both of the devices are designed for use with Philips’ Intellispace Corsium software. This web-based platform is used to record and upload data real-time, and it can be used for communication. This adds to the utility of these devices for healthcare personnel while in transit.

Tempus ALS

The Tempus ALS is a remote monitor and defibrillator. It is lightweight, at only seven pounds. This device comes equipped with both USB and wireless interfaces, which allow it to provide video laryngoscopy and ultrasound without requiring other standalone devices.

The Tempus ALS carries around 10 hours and 45 minutes of use with brightness at 60%. It can be sued with either wired or wireless connections, and has Cat5, Wi-Fi, 3G, and Bluetooth connectivity. Philips’ Enhanced Data Service protocol for storing data is used to ensure that even when connectivity is poor, patient data is transferred safely and effectively. Data is streamed automatically when the patient is initially assessed, as well as when the patient is transported.

Tempus Pro

The Tempus Pro is a portable vital sign monitoring device. Similarly to the Tempus ALS, it is small and light enough to be carried in one hand, at 6.4 pounds. It is intuitive and user-friendly for medical personnel, including having a touchscreen that can be used while wearing gloves. It contains a daylight-readable color display, with a high-contrast mode for better visibility. It is also night-vision compatible. Both these devices are highly durable and portable, which is imperative to their ability to best serve patients in a variety of environmental conditions.

Arman Voskerchyan, General Manager of Therapeutic Care at Philips, said:

“The integrated remote monitoring and defibrillator solution combined with our web-based software platform will help front line responders provide emergency care, diagnosis and treatment – including defibrillation therapy, data management and clinical and operational efficiency features – in a fully integrated solution.”

Conclusion

These products join the growing list of portable and telemedicine products emerging onto the market. These devices help to provide healthcare providers with more options to treat patients in a variety of environments, while also providing more convenience for patients. These devices could have an impact on the future direction of patient monitoring devices.

For more information on this market, iData’s Patient Monitoring Device Market Reports contain detailed market analyses that are based on primary interviews with industry leaders. Each study covers Units Sold, ASPs, Market Share, Procedural Data, Revenue, Growth Rates, and Market Value for each of the market segments. Request your complimentary research summary today!

Via: Philips Tempus ALS and Tempus Pro, Medgadget